148 related articles for article (PubMed ID: 34260532)
1. Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
Li C; Bu X; Liu Y
Medicine (Baltimore); 2021 Jul; 100(28):e26540. PubMed ID: 34260532
[TBL] [Abstract][Full Text] [Related]
2. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
[TBL] [Abstract][Full Text] [Related]
3. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E
J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308
[TBL] [Abstract][Full Text] [Related]
4. Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study.
Baldassarre D; Veglia F; Gobbi C; Gallus G; Ventura A; Crepaldi G; Fisicaro M; Rimondi S; Ricci G; Mancini M; Bong MG; Collatina S; Sirtori CR
Atherosclerosis; 2000 Aug; 151(2):575-83. PubMed ID: 10924737
[TBL] [Abstract][Full Text] [Related]
5. Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study.
Yokoi H; Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yoshida M
Int Heart J; 2014; 55(2):146-52. PubMed ID: 24632963
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
[TBL] [Abstract][Full Text] [Related]
8. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
[TBL] [Abstract][Full Text] [Related]
9. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients.
Qin X; Li Y; Sun N; Wang H; Zhang Y; Wang J; Li J; Xu X; Liang M; Nie J; Wang B; Cheng X; Li N; Sun Y; Zhao L; Wang X; Hou FF; Huo Y
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):166-172. PubMed ID: 27834686
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Xiaoji Recipe on stability of carotid artery vulnerable plaque in elderly patients with type 2 diabetes mellitus and type H hypertension].
Jing-Hui H; Di Z; Ke X; Hai-Yan Y
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4246-4253. PubMed ID: 33164410
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level].
Fu J; Tang HQ; Qin XH; Mao GY; Tang GF
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2179-83. PubMed ID: 20058594
[TBL] [Abstract][Full Text] [Related]
12. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
[TBL] [Abstract][Full Text] [Related]
13. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs.
Ikeda T; Sakurai J; Nakayama D; Takahashi Y; Matsuo K; Shibuya Y; Gomi T; Moriya H; Kobayashi S
Am J Hypertens; 2004 Jun; 17(6):502-6. PubMed ID: 15177522
[TBL] [Abstract][Full Text] [Related]
15. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
[TBL] [Abstract][Full Text] [Related]
16. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
[TBL] [Abstract][Full Text] [Related]
17. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.
Salonen R; Nyssönen K; Porkkala-Sarataho E; Salonen JT
Am J Cardiol; 1995 Sep; 76(9):34C-39C. PubMed ID: 7572684
[TBL] [Abstract][Full Text] [Related]
18. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.
Mancia G; Parati G; Revera M; Bilo G; Giuliano A; Veglia F; Crepaldi G; Zanchetti A
BMJ; 2010 Mar; 340():c1197. PubMed ID: 20339154
[TBL] [Abstract][Full Text] [Related]
19. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
[TBL] [Abstract][Full Text] [Related]
20. Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.
Wada S; Koga M; Minematsu K; Toyoda K; Suzuki R; Kagimura T; Nagai Y; Aoki S; Nezu T; Hosomi N; Origasa H; Ohtsuki T; Maruyama H; Yasaka M; Kitagawa K; Uchiyama S; Matsumoto M
Stroke; 2019 Jun; 50(6):1586-1589. PubMed ID: 31035902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
